The estimated Net Worth of Daniel J. Brennan is at least $46 Millón dollars as of 22 May 2024. Mr. Brennan owns over 112,075 units of Boston Scientific stock worth over $18,572,008 and over the last 11 years he sold BSX stock worth over $23,395,529. In addition, he makes $4,031,290 as Chief Financial Officer y Executive Vice President at Boston Scientific.
Daniel has made over 64 trades of the Boston Scientific stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 112,075 units of BSX stock worth $8,469,508 on 22 May 2024.
The largest trade he's ever made was selling 112,075 units of Boston Scientific stock on 22 May 2024 worth over $8,469,508. On average, Daniel trades about 15,141 units every 45 days since 2014. As of 22 May 2024 he still owns at least 223,921 units of Boston Scientific stock.
You can see the complete history of Mr. Brennan stock trades at the bottom of the page.
Daniel J. Brennan CPA serves as Chief Financial Officer, Executive Vice President of the Company. he is our executive vice president and chief financial officer, a position he has held since January 2014. In this role, he is responsible for several company functions, including Global Controllership, Global Internal Audit, Corporate Finance, Treasury, Corporate Tax, Investor Relations, and Corporate Business Development. Prior to that, he was the Company's senior vice president and corporate controller, a role he served in since January 2010. Since joining Boston Scientific in December 1996, Mr. Brennan has held roles with increased responsibilities, including vice president and assistant corporate controller, vice president of Finance and Information Technology for Worldwide Financial & Strategic Planning, Investor Relations, International Finance and Cardiovascular, group controller of the non-vascular business and controller of the Meditech Vascular business. He holds a B.S. degree in Finance and Investments and an M.B.A from Babson College. Mr. Brennan is also a certified public accountant and a member of the board of overseers of Babson College. He currently is a member of the Board of Directors of Nuance Communications.
As the Chief Financial Officer y Executive Vice President of Boston Scientific, the total compensation of Daniel Brennan at Boston Scientific is $4,031,290. There are 1 executives at Boston Scientific getting paid more, with Michael Mahoney having the highest compensation of $15,764,100.
Daniel Brennan is 54, he's been the Chief Financial Officer y Executive Vice President of Boston Scientific since 2014. There are 20 older and 6 younger executives at Boston Scientific. The oldest executive at Boston Scientific Corp. is Yoshiaki Fujimori, 69, who is the Independent Director.
Daniel's mailing address filed with the SEC is 300 BOSTON SCIENTIFIC WAY, , MARLBOROUGH, MA, 01752-1234.
Over the last 20 years, insiders at Boston Scientific have traded over $938,841,783 worth of Boston Scientific stock and bought 1,398,972 units worth $16,231,539 . The most active insiders traders include Peter M Nicholas, John E Abele y Michael F Mahoney. On average, Boston Scientific executives and independent directors trade stock every 3 days with the average trade being worth of $4,899,929. The most recent stock trade was executed by Michael F Mahoney on 5 September 2024, trading 162,777 units of BSX stock currently worth $13,212,609.
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
Boston Scientific executives and other stock owners filed with the SEC include: